GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (BSP:C1NC34) » Definitions » Research & Development

Centene (BSP:C1NC34) Research & Development : R$0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Centene Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Centene's Research & Development for the three months ended in Mar. 2024 was R$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was R$0 Mil.

Centene Research & Development Historical Data

The historical data trend for Centene's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centene Research & Development Chart

Centene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Centene Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Centene Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Centene  (BSP:C1NC34) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Centene Research & Development Related Terms

Thank you for viewing the detailed overview of Centene's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Centene (BSP:C1NC34) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (BSP:C1NC34) » Definitions » Research & Development
Comparable Companies
HUM MOH OSCR ALHC CLOV NEUE MRAI PFHO CVS CI UNH ELV BSP:ODPV3 SZSE:000503 NSE:MEDIASSIST BJSE:870656 BSP:QUAL3 ROCO:6665 MIL:HI TSXV:NXG
Traded in Other Exchanges
CNC:USA CNC:Mexico 1CNC:Italy QEN:Germany
Address
7700 Forsyth Boulevard, Centene Plaza, St. Louis, MO, USA, 63105
Website
https://www.centene.com
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.

Centene (BSP:C1NC34) Headlines

No Headlines